In situ hybridization study of myelin protein mRNA in rats with an experimental diabetic neuropathy

Neuroscience Letters

Volumn 207, Issue 1, 1996, Pages 65-69

  Conti, Anna Maria ^a   Scarpini, Elio ^a   Malosio, Maria Luisa ^a   Di Giulio, Anna Maria ^a   Baron, Pierluigi ^a   Scarlato, Guglielmo ^a   Mantegazza, Paolo ^a   Gorio, Alfredo ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Experimental diabetic neuropathy; In situ hybridization; Myelin basic protein (MBP); Myelin induced diabetes; Peripheral nerve; Protein zero (P0)

Indexed keywords

ALLOXAN; INSULIN; MESSENGER RNA; MYELIN BASIC PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETIC NEUROPATHY; GENE EXPRESSION; IN SITU HYBRIDIZATION; NONHUMAN; PRIORITY JOURNAL; RAT; SCHWANN CELL; SCIATIC NERVE;

EID: 0029875045     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3940(96)12490-3     Document Type: Article

References (27)

1. 0 glycoprotein in the chick. In E. Scarpini, M.G. Fiori, D. Pleasure and G. Scarlato, Peripheral nerve development and regeneration: recent advances and clinical applications, 19 (1989) 19-23.
2. 1 protein of rabbit sciatic nerve myelin, Arch. Biochem. Biophys., 153 (1972) 590.
3. Campagnoni, A.T., Molecular biology of myelin proteins from the CNS, J. Neurochem., 51 (1988) 1-14.
4. Conti, A.M., Malosio, M.L., Scarpini, E., Di Giulio, A.M., Scarlato, G., Mantegazza, P. and Gorio, A., Myelin protein transcript increase in experimental diabetic neuropathy, Neurosci. Lett., 161 (1993) 203-206.
5. Deibler, GPE., Driscoll, B.F. and Kies, M.W., Immunochemical and biochemical studies demonstrating the identity of a bovine spinal cord protein (SCP) and a basic protein of bovine peripheral nerve myelin (BF), J. Neurochem., 30 (1978) 401.
6. Dyck, P.J., Hypoxic neuropathy: does hypoxia play a role in diabetic neuropathy?, Neurology, 39 (1989) 111-118.
7. Eliasson, S.G., Nerve conduction changes in experimental diabetes, J. Clin. Invest., 43 (1964) 2353-2358.
8. Feinberg, A.P. and Vogelstein, B., A technique for radiolabelling DNA restriction endonuclease fragments to high specific activity, Anal. Biochem., 132 (1983) 6-13.
9. Feinberg, A.P. and Vogelstein, B., Addendim: a technique for radiolabelling DNA restriction endonuclease fragments to high specific activity, Anal. Biochem., 137 (1983) 266-272.
10. Giannini, C. and Dyck, P.J., Ultrastructural morphometric abnormalities of sural nerve endoneurial microvessels in diabetes mellitus, Ann. Neurol., 36(3) (1994) 408-415.
11. Greene, D.A., Lattimer, A.S. and Sima, A.F., Sorbitol, phosphoinositides, and sodium-potassium-ATPase in the pathogenesis of diabetic complications, N. Engl. J. Med., 316 (1987) 599-606.
12. Greenfield, S., Brostoff, S.W., Eylar, E.H. and Morell, P., Protein composition of myelin of the peripheral nervous system, J. Neurochem., 20 (1973) 1207.
13. Hellweg, R. and Hartung, H.-D., Endogenous levels of nerve growth factor (NGF) are altered in experimental diabetes mellitus: a possible role for NGF in the pathogenesis of diabetic neuropathy, J. Neurosci. Res., 26 (1990) 258-267.
14. Lemke, G., The molecular genetics of myelination: an update, Glia, 7 (1993) 263-271.
15. Lemke, G. and Axel, R., Isolation and sequence of a cDNA encoding the major structural protein of peripheral myelin, Cell, 40 (1985) 501-508.
16. Lukens, F.D.W., Alloxan diabetes, Physiol. Rev., 28 (1948) 304-330.
17. Norido, F., Canella, R., Zanoni, R. and Gorio, A., The development of diabetic neuropathy in the C57BL/KS (db/db) mouse and its treatment with gangliosides, Exp. Neurol., 83 (1984) 221-223.
18. Roach, A., Boylan, K., Horvath, S., Prusiner, S. B. and Hood, L.E. Characterization of cloned cDNA representing rat myelin basic protein: absence of expression in brain of Shiverer mutant mice, Cell, 34 (1984) 799-806.
19. Scarpini, E., Lisak, R.P., Beretta, S., Velicogna, M.E., Doronzo, R., Moggio, M., Jann, S. and Scarlato, G., Quantitative assessment of class II molecules in normal and pathological nerves. Brain, 113 (1990) 659-675.
20. Sidenius, P., The axonopathy of diabetic neuropathy, Diabetes, 31 (1982) 689-693.
21. Sidenius, P. and Jakobsen, J., Axonal transport in early experimental diabetes, Brain Res., 173 (1979) 315-330.
22. Sima, A.A.F., Lattimer, S.A., Yagihashi, S. and Greene, D.A., Axoglial dysjunction: a novel structural lesion responsible for poorly reversible nerve conduction slowing in the spontaneously diabetic BB rat, J. Clin. Invest., 77 (1986) 474-479.
23. Sima, A.A.F., Nathanie, V., Bril, V., McEwen, T. and Greene, D., Histopathological heterogeneity of neuropathy in insulin-dependent and non-insulin-dependent diabetes, and demonstration of axo-glial dysjunction in human diabetic neuropathy, J. Clin. Invest., 81 (1988) 349-364.
24. Sima, A.A.F., Zang, W.X., Tze, W.J., Tai, J. and Nathaniel, V., Diabetic neuropathy in the streptozotocin diabetic rat and the effect of allogenic islet cell transplantation, Diabetes, 37 (1988) 1129-1136.
25. Thomas, P.K., Diabetic neuropathy: models, mechanisms and mayhem, Can. J. Neurol. Sci., 19 (1992) 1-7.
26. Vitadello, M., Couraud, J.Y., Hassig, R., Gorio, A. and Di Giamberardino, L., Altered axonal transport of cytoskeletal proteins in the mutant diabetic mouse, J. Neurochem., 45 (1985) 850-868.
27. Weskamp, G. and Otten, U., An enzyme-linked immunoassay for nerve growth factor (NGF): a tool for studying regulatory mechanisms involved in NGF production in brain and in peripheral tissues, J. Neurochem.,. 48 (1990) 1779-1786.